On September 26, 2023, Forte Biosciences Inc announced that it held its 2023 annual meeting of shareholders on September 19, 2023 and declared the voting results. As there has been no further engagement between BML Investment Partners LP and Forte Biosciences Inc, hence the campaign is considered to have been withdrawn.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5803 USD | -0.12% | -10.86% | -29.38% |
May. 30 | Brookline Capital Initiates Forte Biosciences at Buy Rating With $4 Price Target | MT |
May. 13 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.38% | 21.15M | |
+16.79% | 121B | |
+13.67% | 107B | |
-5.44% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.23% | 15.31B | |
+3.22% | 14.08B | |
+24.53% | 11.74B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Declaration of Voting Results by Forte Biosciences